U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H13N5O3.H2O
Molecular Weight 269.2572
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2'-DEOXYADENOSINE MONOHYDRATE

SMILES

O.NC1=NC=NC2=C1N=CN2[C@H]3C[C@H](O)[C@@H](CO)O3

InChI

InChIKey=WZJWHIMNXWKNTO-VWZUFWLJSA-N
InChI=1S/C10H13N5O3.H2O/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7;/h3-7,16-17H,1-2H2,(H2,11,12,13);1H2/t5-,6+,7+;/m0./s1

HIDE SMILES / InChI

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C10H13N5O3
Molecular Weight 251.2419
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

2′-Deoxyadenosine, a pair of deoxythymidine (T) in double-stranded DNA, is a substrate of adenosine deaminase. In case of absence of this enzyme, 2′-deoxyadenosine accumulates in T lymphocytes and kills these cells resulting in a genetic disorder known as adenosine deaminase severe combined immunodeficiency disease (ADA-SCID).

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P00813
Gene ID: 100.0
Gene Symbol: ADA
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Altered deoxynucleoside triphosphate levels paralleling deoxyadenosine toxicity in adenosine deaminase inhibited human lymphocytes.
1980
Resistance of pokeweed mitogen-stimulated B cells to inhibition by deoxyadenosine.
1980 Jul
Antiviral, antimetabolic and antineoplastic activities of 2'- or 3'-amino or -azido-substituted deoxyribonucleosides.
1980 Jun 15
Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.
1980 Nov
A comparison of the carcinogen-DNA adducts formed in rat liver in vivo after administration of single or multiple doses of N-methyl-4-aminoazobenzene.
1981 Dec
Adenosine and deoxyadenosine toxicity in colony assay systems for human T-lymphocytes, B-lymphocytes, and granulocytes.
1982
S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
1983 Jul
Nucleotide levels and metabolism of adenosine and deoxyadenosine in intact erythrocytes deficient in adenosine deaminase.
1984
Analytical DNA flow cytometric analysis of deoxyadenosine toxicity in cultured human leukemic lymphoblasts.
1984 Sep
Purine metabolizing enzymes as predictors of lymphoblast sensitivity to deoxyadenosine.
1984 Sep
Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging tools.
1989 Sep
High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count.
1993 Apr
Rapid radioassay for metabolites of adenosine and deoxyadenosine in erythrocytes.
1995 Dec 1
Determination of adenosine and deoxyadenosine in urine by high-performance liquid chromatography with column switching.
1998 Nov 20
1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism.
1999 Apr
Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain.
2000 Dec 1
Phosphorylation of the anti-HIV compound (S,S)-isodideoxyadenosine by human recombinant deoxycytidine kinase.
2000 Nov 15
Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency.
2001 Jul
5'-Esters of 2'-deoxyadenosine and 2-chloro-2'-deoxyadenosine with cell differentiation-provoking agents.
2002
Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1.
2002 Sep
Selectivity of purine alkylation by a quinone methide. Kinetic or thermodynamic control?
2003 Aug 8
Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1.
2003 Sep 15
Characterization of glycine N-methyltransferase from rabbit liver.
2004 Jun
Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity.
2014 Jan 6
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:55:37 GMT 2023
Edited
by admin
on Fri Dec 15 15:55:37 GMT 2023
Record UNII
F79D3BS9UH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2'-DEOXYADENOSINE MONOHYDRATE
Systematic Name English
ADENOSINE, 2'-DEOXY-, HYDRATE (1:1)
Systematic Name English
ADENOSINE, 2'-DEOXY-, MONOHYDRATE
Systematic Name English
Code System Code Type Description
FDA UNII
F79D3BS9UH
Created by admin on Fri Dec 15 15:55:37 GMT 2023 , Edited by admin on Fri Dec 15 15:55:37 GMT 2023
PRIMARY
EPA CompTox
DTXSID801036040
Created by admin on Fri Dec 15 15:55:37 GMT 2023 , Edited by admin on Fri Dec 15 15:55:37 GMT 2023
PRIMARY
CAS
16373-93-6
Created by admin on Fri Dec 15 15:55:37 GMT 2023 , Edited by admin on Fri Dec 15 15:55:37 GMT 2023
PRIMARY
PUBCHEM
9549172
Created by admin on Fri Dec 15 15:55:37 GMT 2023 , Edited by admin on Fri Dec 15 15:55:37 GMT 2023
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE